Medicaid’s Multiple Best Price Proposal Needs More Clarity Before Advancing, PhRMA Argues
Medicaid should go back to the drawing board on a key part of its proposal aimed at circumventing best price reporting obstacles to value-based purchasing.
Medicaid should go back to the drawing board on a key part of its proposal aimed at circumventing best price reporting obstacles to value-based purchasing.